{"entity":{"type":"insider","cik":"0001527710","url":"/insider/0001527710","json_url":"/insider/0001527710.json","name":"Tursi James Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2014-11-24","last":"2018-05-16","span_basis":"filed_date"},"name_variants":[{"name":"Tursi James Patrick","source":"filing","n_filings":8,"first_seen":"2014-11-24","last_seen":"2018-05-16"}],"transactions":[{"id":5983733,"accession":"0001104659-18-033905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-033905","line_url":"/filing/0001104659-18-033905#line-1","is_derivative":false,"issuer_cik":"0001527710","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001527710","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9348.0,"shares_display":"9,348","price_per_share":0.5222,"price_display":"0.52","price_state":"stated","total_value":4881.5256,"total_display":"4,881.53","total_whole":"4,882","shares_owned_after":242052.0,"shares_owned_after_display":"242,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-16","scope":"insider"},{"id":5983552,"accession":"0001104659-18-019364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-019364","line_url":"/filing/0001104659-18-019364#line-1","is_derivative":false,"issuer_cik":"0001527710","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001527710","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5950.0,"shares_display":"5,950","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":10115.0,"total_display":"10,115.00","total_whole":"10,115","shares_owned_after":251400.0,"shares_owned_after_display":"251,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":4773496,"accession":"0001179110-17-013135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-013135","line_url":"/filing/0001179110-17-013135#line-1","is_derivative":false,"issuer_cik":"0001527710","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001527710","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9960.0,"shares_display":"9,960","price_per_share":2.5018,"price_display":"2.50","price_state":"stated","total_value":24917.928,"total_display":"24,917.93","total_whole":"24,918","shares_owned_after":257350.0,"shares_owned_after_display":"257,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4221359,"accession":"0001104659-17-017605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-017605","line_url":"/filing/0001104659-17-017605#line-1","is_derivative":false,"issuer_cik":"0001527710","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001527710","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4750.0,"shares_display":"4,750","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":10022.5,"total_display":"10,022.50","total_whole":"10,023","shares_owned_after":184118.0,"shares_owned_after_display":"184,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"},{"id":3162594,"accession":"0001104659-16-122649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-122649","line_url":"/filing/0001104659-16-122649#line-1","is_derivative":false,"issuer_cik":"0001527710","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001527710","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":37500.0,"total_display":"37,500.00","total_whole":"37,500","shares_owned_after":179368.0,"shares_owned_after_display":"179,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2421321,"accession":"0001104659-16-121880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-121880","line_url":"/filing/0001104659-16-121880#line-1","is_derivative":false,"issuer_cik":"0001527710","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001527710","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":3.7861,"price_display":"3.79","price_state":"stated","total_value":17037.45,"total_display":"17,037.45","total_whole":"17,037","shares_owned_after":169368.0,"shares_owned_after_display":"169,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":6449169,"accession":"0001209191-14-071388","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-071388","line_url":"/filing/0001209191-14-071388","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13713.0,"shares_display":"13,713","price_per_share":34.12299486618537,"price_display":"34.12","price_state":"stated","total_value":467928.6286,"total_display":"467,928.63","total_whole":"467,929","shares_owned_after":35055.0,"shares_owned_after_display":"35,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-26","scope":"insider","n_lines":2},{"id":6769563,"accession":"0001209191-14-070835","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-070835","line_url":"/filing/0001209191-14-070835","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8648.0,"shares_display":"8,648","price_per_share":33.46930018501388,"price_display":"33.47","price_state":"stated","total_value":289442.508,"total_display":"289,442.51","total_whole":"289,443","shares_owned_after":35055.0,"shares_owned_after_display":"35,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-24","scope":"insider","n_lines":2},{"id":6769553,"accession":"0001209191-14-070835","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-070835","line_url":"/filing/0001209191-14-070835","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001527710","owner_name":"Tursi James Patrick","owner_display_name":"Tursi James Patrick","owner_url":"/insider/0001527710","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66000.0,"shares_display":"66,000","price_per_share":33.1534,"price_display":"33.15","price_state":"stated","total_value":2188124.4,"total_display":"2,188,124.40","total_whole":"2,188,124","shares_owned_after":43703.0,"shares_owned_after_display":"43,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-24","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660719","name":"Aralez Pharmaceuticals Inc.","url":"/issuer/0001660719","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2016-05-18","last_seen":"2018-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2014-11-24","last_seen":"2014-11-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001527710","retrieved_at":"2026-08-24T15:45:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}